KnowTheStock
Log inCreate free account

Idexx Laboratories, Inc.

IDXX
S&P 500Nasdaq 100In-Vitro Diagnostic Substance Manufacturing · NASDAQ
$535.93last close · market cap 42.51 Billion
Compare with…
75.2SCORE / 100
Our verdictHOLDStrong Growth and ImprovingQtr Ending 2026-06-30 · trend positive

Why Hold

Income statement, balance sheet and cash flow are strong.

Next earnings: 2026-11-02 (BMO), EPS Forecast: $3.71

What is strong
  • Revenue Growth is 12.77%
  • Operating Income Growth is 16.21%
  • Net Income Growth is 15.62%
  • Earnings Per Share (EPS) Growth is 18.6%
  • Net Margin is 25.03%
  • Current Debt to Net Income Ratio is 0.44
  • Total Debt to Total Assets Ratio is 0.13
  • Cash from Operations Growth is 51.41%
  • Capital Expenditure is Low
  • Net Increase in Cash is Positive
What to watch
  • Current Asset to Current Liability Ratio is 1.17
  • Debt Ratio is 0.53
  • Investment Risk is High

What changed

Score by quarter

Upgraded from Sell to Hold in the Mar 2026 quarter: 68.8 → 74.2 (+5.4). This quarter: +1.0.

607080Sep 2022Jun 2026

What the score is made of

Income statement82.4 +0.0
Balance sheet61.2 +6.3
Cash flow76.4 -5.1

Change vs previous quarter.

Key numbers · latest quarter

Revenue (TTM)4.55 Billion12.77 % growth
EPS14.2218.60 % growth
Profit margin25.03 %Profit per $1 of sales
P-E ratio—Not available
Market cap42.51 BillionShares × price
Debt-equity ratio0.28Leverage
Dividend0.00Per share, annual
Next earnings2026-11-02BMO · EPS forecast $3.71
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.

About Idexx Laboratories, Inc.

IDEXX Laboratories, Inc. is a member of the S&P 500® Index and is a leader in pet healthcare innovation, offering diagnostic and software products and services that deliver solutions and insights to practicing veterinarians around the world. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk and point-of-care and laboratory diagnostics for human medicine. Headquartered in Maine, IDEXX employs more than 9,000 people and offers products to customers in over 175 countries.

CEO
Jonathan Jay Mazelsky
Employees
10,780
Sector
Manufacturing
Exchange
NASDAQ
www.idexx.com

Similar stocks

Loading…